Aberrant/JJ
splicing/NN
of/IN
the/DT
TSG101/NN
and/CC
FHIT/NN
genes/NNS
occurs/VBZ
frequently/RB
in/IN
multiple/JJ
malignancies/NNS
and/CC
in/IN
normal/JJ
tissues/NNS
and/CC
mimics/VBZ
alterations/NNS
previously/RB
described/VBN
in/IN
tumours/NNS
./.

Intragenic/JJ
deletions/NNS
of/IN
TSG101/NN
,/,
the/DT
human/JJ
homolog/NN
of/IN
a/DT
mouse/NN
gene/NN
(/(
tsg101/NN
)/)
that/WDT
acts/VBZ
to/TO
suppress/VB
malignant/JJ
cell/NN
growth/NN
,/,
were/VBD
reported/VBN
in/IN
human/JJ
breast/NN
tumours/NNS
./.
=====
We/PRP
screened/VBD
TSG101/NN
for/IN
somatic/JJ
mutations/NNS
in/IN
DNA/NN
and/CC
RNA/NN
samples/NNS
isolated/VBN
from/IN
a/DT
variety/NN
of/IN
common/JJ
human/JJ
malignancies/NNS
,/,
EBV-immortalised/JJ
B-cells/NNS
,/,
and/CC
normal/JJ
lung/NN
parenchyma/NN
./.
=====
Intragenic/JJ
TSG101/NN
deletions/NNS
in/IN
RNA/NN
transcripts/NNS
were/VBD
frequently/RB
found/VBN
in/IN
all/DT
types/NNS
of/IN
samples/NNS
./.
=====
Analysis/NN
of/IN
DNA/NN
failed/VBD
to/TO
show/VB
genomic/JJ
rearrangements/NNS
corresponding/VBG
to/TO
transcripts/NNS
containing/VBG
deletions/NNS
in/IN
the/DT
same/JJ
samples/NNS
./.
=====
The/DT
breakpoints/NNS
of/IN
most/JJS
transcript/NN
deletions/NNS
coincide/VBP
with/IN
genuine/JJ
or/CC
cryptic/JJ
splice/NN
site/NN
sequences/NNS
,/,
suggesting/VBG
that/IN
they/PRP
result/VBP
from/IN
alternative/JJ
or/CC
aberrant/JJ
splicing/NN
./.
=====
A/DT
similar/JJ
spectrum/NN
of/IN
transcript/NN
deletions/NNS
has/VBZ
previously/RB
been/VBN
described/VBN
in/IN
the/DT
putative/JJ
tumour/NN
suppressor/NN
gene/NN
FHIT/NN
./.
=====
We/PRP
analysed/VBD
FHIT/NN
in/IN
the/DT
same/JJ
series/NN
of/IN
RNA/NN
samples/NNS
and/CC
detected/VBD
truncated/VBN
FHIT/NN
transcripts/NNS
frequently/RB
in/IN
both/CC
tumour/NN
and/CC
normal/JJ
tissues/NNS
./.
=====
In/IN
addition/NN
,/,
transcripts/NNS
from/IN
TSG101/NN
,/,
FHIT/NN
and/CC
seven/CD
other/JJ
genes/NNS
were/VBD
analysed/VBN
in/IN
RNA/NN
isolated/VBN
from/IN
normal/JJ
peripheral/JJ
blood/NN
lymphocytes/NNS
./.
=====
Large/JJ
TSG101/NN
and/CC
FHIT/NN
intragenic/JJ
transcript/NN
deletions/NNS
were/VBD
detected/VBN
and/CC
these/DT
appeared/VBD
to/TO
be/VB
the/DT
predominant/JJ
transcript/NN
in/IN
'/``
aged/JJ
'/''
lymphocytes/NNS
./.
=====
Similar/JJ
alterations/NNS
were/VBD
not/RB
detected/VBN
in/IN
transcripts/NNS
of/IN
the/DT
other/JJ
genes/NNS
which/WDT
were/VBD
analysed/VBN
./.
=====
Our/PRP$
findings/NNS
demonstrate/VBP
that/IN
truncated/VBN
TSG101/NN
and/CC
FHIT/NN
transcripts/NNS
are/VBP
commonly/RB
detected/VBN
in/IN
both/CC
normal/JJ
and/CC
malignant/JJ
tissues/NNS
and/CC
that/IN
a/DT
significant/JJ
fraction/NN
of/IN
these/DT
are/VBP
likely/JJ
to/TO
be/VB
the/DT
result/NN
of/IN
aberrant/JJ
splicing/NN
./.
=====
While/IN
we/PRP
can/MD
not/RB
exclude/VB
that/IN
alterations/NNS
in/IN
TSG101/NN
and/CC
FHIT/NN
occur/VBP
during/IN
cancer/NN
development/NN
,/,
our/PRP$
data/NNS
indicate/VBP
that/IN
in/IN
this/DT
context/NN
the/DT
commonly/RB
observed/VBN
transcript/NN
abnormalities/NNS
are/VBP
misleading/JJ
./.